Fengyan Pei
- Infectious Diseases
- Molecular Biology
- Epidemiology
- Biomedical Engineering
- Molecular Medicine top 10%
- Topics
- SARS-CoV-2 and COVID-19 Research (3 papers)Epigenetics and DNA Methylation (2 papers)Cervical Cancer and HPV Research (2 papers)
- Partner nations
- ChinaAustraliaSouth Korea
In The Last Decade
Fengyan Pei
19 papers receiving 349 citations
Peers
Comparison fields: 5 of 87
- Infectious Diseases 105
- Molecular Biology 90
- Epidemiology 71
- Biomedical Engineering 56
- Molecular Medicine 41
Countries citing papers authored by Fengyan Pei
This map shows the geographic impact of Fengyan Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengyan Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengyan Pei more than expected).
Fields of papers citing papers by Fengyan Pei
This network shows the impact of papers produced by Fengyan Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengyan Pei. The network helps show where Fengyan Pei may publish in the future.
Co-authorship network of co-authors of Fengyan Pei
This figure shows the co-authorship network connecting the top 25 collaborators of Fengyan Pei. A scholar is included among the top collaborators of Fengyan Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengyan Pei. Fengyan Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 64 | |
| 4 | 55 | |
| 5 | 9 | |
| 6 | 23 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 34 | |
| 10 | 4 | |
| 11 | 41 | |
| 12 | 7 | |
| 13 | 8 | |
| 14 | 11 | |
| 15 | 13 | |
| 16 | Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis. | 27 |
| 17 | 9 | |
| 18 | 19 | |
| 19 | 10 |
About Fengyan Pei
Fengyan Pei is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases, having authored 19 papers that have together received 351 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Epigenetics and DNA Methylation (2 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (18 citations), Molecular Medicine (41 citations) and Infectious Diseases (105 citations). Fengyan Pei has collaborated with scholars based in China, Australia and South Korea. Frequent co-authors include Mingyu Ji, Yunshan Wang, Qianqian Zhao, Yunying Zhou, Qingxi Wang, Huanjie Li, Weihua Yang, Li Wang, Huailong Zhao and Chengjin Hu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.